UroGen Appoints Chris Degnan as Chief Financial Officer
Go back to UroGen Appoints Chris Degnan as Chief Financial Officer| (NASDAQ: URGN) | Delayed: 49.00 +1.89 (4.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.11 | 52 Week High | $ | |||
| Open | $47.49 | 52 Week Low | $ | |||
| Day High | $49.67 | P/E | N/A | |||
| Day Low | $47.12 | EPS | $ | |||
| Volume | 1,701,237 | |||||

